Staphylococcus aureus are widely considered a major factor of nosocomial and community-acquired infections. This work was aimed at determining the prevalence of methicillin-resistant S. aureus (MRSA) among apparently healthy students.
INTRODUCTION
The widespread resistance across various species of staphylococci has been reported in recent years. (1) The most notable example is the emergence of methicillin-resistant Staphylococcus aureus (MRSA), which was reported just one year after the launch of methicillin in the early 1960s and has now become a major public health concern with its prevalence increasing globally. (2) MRSA can cause the same types of infections as other S. aureus isolates such as: skin and soft tissue infections, including impetigo, folliculitis, furunculosis, abscesses, cellulitis, and wound infections. (2) The MRSA has also been reported to cause invasive infections such as: pneumonia, endocarditis, osteomyelitis, septic arthritis, meningitis, septicemia, toxic shock and staphylococcal scalded skin syndromes in both infants and adults. (2) The MRSA strains are resistant to nearly all beta-lactam antibiotics by producing an alternative penicillin-binding protein (PBP) known as PBP-2a. (3) This protein is encoded by the mecA gene and has a low affinity to many beta-lactam antibiotics. MRSA strains are not only resistant to beta-lactams and cephalosporins, but also often show resistance to a wide range of antibiotics. (3) The mecA is part of a mobile genetic element called staphylococcal cassette chromosome (SCCmec). The SCCmec is flanked by cassette chromosome recombinase genes (ccrA or ccrB or ccrC) that permit intra-and interspecies horizontal transmission of SCCmec. (3, 4) S. aureus has four PBPs, (PBP1, PBP2, PBP3, and PBP4), with PBP2a/2' and PBP2 being responsible for peptidoglycan synthesis with transpeptidase and transglycosylase activities. (3) In Nigeria, the prevalence of hospital associated-MRSA in clinical samples also varies from one region to another; 19.2% in Ekiti, 28.6% in Kano, 12.5% in Maiduguri and 38.0% in Benin. (5) (6) (7) (8) (9) Several reports of studies on prevalence of community-associated MRSA (CA-MRSA) are also emerging in Nigeria; 10.8% in apparently healthy school children in Okada, Edo State, 41% and 56.7% in apparently healthy university students in Edo and Ogun states respectively, and 60.7% in otherwise healthy inhabitants of Uturu communities in Abia State. (10) (11) (12) Characterization of the 16S rRNA gene is now well-established as a standard method for identifying and classifying species, genera and families of bacteria including staphylococci. (13) The nuc gene, which encodes thermonuclease, is widely used as a specific target for the identification of S. aureus by polymerase chain reaction (PCR). (14) Numerous in-house PCR based assays targeting the nuc gene alone or in combination with the mecA gene have been designed for fast screening or identification of methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA). (14) In recent years, detection of mecA by PCR is also considered as the gold standard for identification of MRSA. (9, 14) Cefoxitin, being a cephamycin, is a stronger inducer of the mecA regulatory system than oxacillin. The cefoxitin disc test is easier to read than the oxacillin disc diffusion test and more accurate for detection of mecA mediated resistance. (15) Many PCR based molecular methods were developed as alternative ways for accurate identification of MRSA. (16) Most reports in our locality concentrate on phenotypic methods of identifying methicillin-resistant staphylococci especially among apparently healthy subjects and neglecting molecular characterization to identify the specific bacteria and genes responsible for antimicrobial resistance. This study therefore aimed to use the PCR assay to target three genes: a genusspecific 16S rRNA to detect staphylococcal DNA; nuc, which encodes the S. aureusspecific region of the thermonuclease gene and mecA, a determinant of methicillin resistance among apparently healthy students of a tertiary institution in Auchi, Edo State, Nigeria.
METHODS

Research design
This study was of cross-sectional design and was conducted using 400 apparently healthy students (consisting of 167 males and 233 females) of Auchi Polytechnic, Auchi, Edo State, Nigeria. Informed consent was obtained from all participants prior to specimen collection. Institutional ethical approval was obtained before study commencement. The duration of the study was from July 2016 to November 2017.
Specimen collection and processing
A total of 400 anterior nasal swab specimens were collected from the participants. All samples were collected from the left anterior nares using sterile swab stick soaked in sterile saline, labelled, packaged and transported immediately to the Microbiology laboratory for analysis. Staphylococcus aureus isolates were identified using API-Staph system (API System; bioMerieux, Paris, France).
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was carried out following the recommendation of the British Society for Antimicrobial Chemotherapy (BSAC) method. (17) The test colonies were emulsified in sterile distilled water and the turbidity matched with 0.5 McFarland. Once matched, a sterile cotton wool swab was dipped in the organism suspension and excess liquid was removed by turning the swab on side of the test tube. The entire surface of Mueller-Hinton agar plate was seeded by swabbing in three directions with the swab. The antibiotic discs were placed on the plate with the use of a sterile forceps. The antimicrobial agents tested were ofloxacin (5µg), amoxicillin-clavulanate (30µg), ceftazidime (30g), erythromycin (5µg), cloxacillin (5µg), ceftriaxone (30µg), cefuroxime (30µg) and gentamicin (10µg). The plates were incubated at 37 0 C for 18 -24 hours.
Detection of cefoxitin resistance
All Staphylococcus aureus isolated were screened for methicillin-resistance by following CLSI guidelines using 30 μg cefoxitin discs (Abtek U.K). (15) Plates were read after incubation at 35°C for 18 h. Zone diameter d" 21mm was deemed to indicate cefoxitin resistance.
Bacterial DNA extraction
Bacterial DNA extraction was done on the 23 cefoxitin-resistant staphylococci isolates only. The DNA of the representative bacterial isolates was extracted using ZR fungal/bacterial DNA Mini Prep TM kit (Zymo Research Corporation, USA) following the manufacturer's instruction.
PCR amplification of 16S rRNA, nuc and mecA genes
The 23 cefoxitin-resistant staphylococci eluted DNA extracts were amplified for 16S rRNA, nuc and mecA genes by PCR using their respective primers as shown in Table 1 . Briefly, a volume of 25μl PCR reaction mixture consisting of 12.5μl of PCR master mix, primers (1.25μl each), double distilled water (5μl), and DNA template (5μl) was used for PCR.
Univ Med
Vol. Amplifications were performed using GeneAmp* PCR system 9700 thermocycler (Applied Biosystems, USA) beginning with an initial denaturation at 94º C for 3 min followed by 30 cycles of 30 s denaturation step at 94ºC, annealing at 57º C for 30 s, extension at 72º C for 30 s, and a final 7 min extension at 72ºC followed by a hold at 4 o C. The 10µl of PCR products was electrophoresed on 1% Trisacetate-EDTA agarose gel stained with ethidium bromide for 60 min with 90V current and viewed under UV trans illuminator (Dolphin-DOC plus, Wealtec Corporation). (18) 
Statistical analysis
Statistical analysis was by the Chi (X 2 ) square test and Fischer's exact test where appropriate using INSTAT® software. A p value of <0.05 was deemed statistically significant.
Ethical approval
Ethical approval for this study was sought and obtained from Auchi Polytechnic Health Ethical Committee, Auchi with registration number: AP/HC.14/VOL.1/69.
RESULTS
Out of 400 apparently healthy students screened, 229 (57.3%) were culture positive for S. aureus. Twenty-three (7.7%) of these isolates were methicillin resistant using cefoxitin disc. This comprised 8 (8.1%) males and 15 (11.5%) females. Gender did not however significantly affect the distribution of MRSA (p=0.5219) ( Table 2 ).
The prevalence of specific genes 16S rRNA, nuc and mecA among cefoxitin-resistant S. aureus was 100%, 100%, and 69.6% A B C Table 2 . Prevalence rate of MRSA isolated from the nares of apparently healthy students using cefoxitin disc Figure 1 . Polymerase chain reaction of 16S rRNA gene in cefoxitin-resistant staphylococci isolates using 1.0% agarose gel electrophoresis stained with ethidium bromide to identify staphylococci. Left-hand lane is 100bp-1517bp DNA ladder (molecular marker) while NC is a no DNA template control Univ Med Vol. 38 No.1 Figure 3 .Polymerase chain reaction results for detection of mecA gene from confirmed cefoxitin-resistant Staphylococcus aureus isolates on 1.0% agarose gel electrophoresis stained with ethidium bromide. L is 100bp-1517bp DNA ladder (molecular marker) while NC is a no DNA template control Figure 2 . Polymerase chain reaction of nuc gene in cefoxitin-resistant staphylococci isolates using 1.0% agarose gel electrophoresis stained with ethidium bromide to identify Staphylococcus aureus. L is 100bp-1517bp DNA ladder (molecular marker) while NC is a no DNA template control respectively. Polymerase chain reaction results for detection of these genes can be seen in Figure  1 , 2, and 3 respectively. Gender also did not significantly affect the distribution of mecA gene among cefoxitin-resistant S. aureus as 16 (69.6%) isolates harbored the gene, in a maleto-female ratio of 6:10 (p=0.975). Methicillin resistant S. aureus showed poor susceptibility to commonly available antibiotics as 0% susceptibility was observed for ceftazidime, cefuroxime, ceftriaxone, cloxacillin and amoxicillin-clavulanate (augmentin). A poor level of susceptibility was recorded among the MRSA namely to erythromycin (26.6%), The most active antibiotic was ofloxacin (60.9%).
DISCUSSION
The prevalence rate of MRSA in this study was 5.8% (using cefoxitin disc). This finding is in agreement with the work of Mahde et al. (19) which reported community-associated MRSA among healthy university students (4.2%). Also, Okwu et al. (10) reported a prevalence of 10.8% of community-associated MRSA in apparently healthy school children in Okada, Edo State, Nigeria. A study carried out in Colombia by Bettin et al. showed that the MRSA carriage status by medical students in their clinical rotations was 1.6%. (20) A study in Thailand reported 1% prevalence among university students while Shadi recorded 6.7% MRSA colonization of nares among medical students in Jeddah, Saudi Arabia. (21, 22) On the contrary, Eke et al. (11) reported 41% MRSA in apparently healthy university students in Ekpoma, Edo State, Nigeria. The difference in prevalence rates recorded could be attributed to method of identification of S. aureus isolates used to detect MRSA. Most other studies in Nigeria reported above used phenotypic identification as against the genotypic method used in this study. Ayeni and Odumosu had reported 85% misidentification rate of other microorganisms as Staphylococus aureus in Southern Nigeria when comparing phenotypic methods with genotypic (16S rRNA). (13) Polymerase chain reaction (PCR) amplification of 16S rRNA genes to identify staphylococci among the 23 MRSA of apparently healthy subjects was positive (100%). This is in line with work of Degaim et al. (23) where all isolates were positive for both 16S rRNA genes and mecA genes (100%). Ayeni and Odumosu similarly showed the reliability of this genotypic test when compared with phenotypic tests in identification of S. aureus. (13) This current study results agreed with Makgotlho, (24) who showed that all isolates 97/97 (100%) have 16S rRNA gene while mecA gene was detected in 96/97 (99%) of the MRSA isolates, the 1/97(1%) which did not show the presence of mecA gene was, however, phenotypically identified as MRSA.
In this study, the PCR amplification of nuc gene to detect Staphylococcus aureus among MRSA showed 100% positive results. According to Vremera et al. (25) the nuc gene in S. aureus encodes the thermonuclease enzyme and amplification of nuc gene is a potential method for rapid diagnosis of S. aureus infection. Therefore, the primer used in this study confirmed the ability of PCR as a fast and reliable method for detection of the nuc gene to identify S. aureus strains. Also, of the 23 MRSA (using phenotypic method), 16 (69.6%) were confirmed to be mecA positive by the PCR method. This is also similar to the work of Ibadin et al. (9) where sensitivity and specificity of mecA gene in detection of MRSA was 89.5% and 90.3% respectively. Phenotypically methicillin-resistant strains without mecA gene and methicillin sensitive strains harboring mecA gene have been shown in previous studies. (13) In this study, phenotypic and genotypic methods for detection of MRSA were used. The results of this study showed that 5.8% and 4.0% of S. aureus isolates were recognized as MRSA by cefoxitin disc diffusion test and PCR method respectively. Considering that detection of the mecA gene by PCR method is a gold standard method for identifying methicillin-resistance in S. aureus isolates, therefore the prevalence of MRSA in this study was 4.0%.
In this study, a poor level of susceptibility was recorded among the MRSA namely to erythromycin (26.6%), cloxacillin (0%), augmentin (0%), cefuroxime (0%), ceftriaxone (0%) and ceftazidime (0%). This implies that MRSA isolates are generally resistant to betalactam antibiotics as previously reported. (9, 10) However, some MRSA isolates were susceptible to gentamicin (47%) and ofloxacin (60.9%). The sensitivity to the non-beta-lactam antibiotics was also similar to previous findings and it is recommended that non-beta-lactam antibiotics should be the preferred drugs for the treatment of community-acquired (CA) MRSA infections. (8, 9) The moderately high resistance (52.2%) recorded for gentamicin was similar to the report on S. aureus from clinical samples (44.4%). (9) Ofloxacin (with sensitivity of 60.9%) appeared to be the best antibiotic of choice for the treatment of MRSA infections in Auchi, Edo State and its surrounding communities. A limitation of this study is hinged on the fact that only phenotypically identified MRSA strains were subjected to molecular analysis. More far reaching recommendations for routine microbiological practice may have been reached if all phenotypically identified S. aureus were screened for the nuc gene. The study however holds important clinical implications as the role of carriers of MRSA is continually being explored in opportunistic infections and nosocomial outbreaks. Further studies that explore nasal carriage of hospital-acquired and community-acquired MRSA strains among apparently healthy subjects may deepen understanding of the superbug-MRSA in our region.
CONCLUSIONS
This present study established the phenotypic and genotypic prevalence rates of MRSA among apparently healthy subjects in the Auchi Polytechnic to be 5.8% and 4.0%, respectively. It showed that the PCR technique is a very useful tool in detecting and identifying MRSA using 16S rRNA, nuc and mecA genes. In comparison with conventional methods, genotypic analysis of these three genes is still the gold standard for detecting MRSA. Ofloxacin was found to be most effective antibiotic against MRSA.
